AlphaYouOKUR: Leverone Jason A. discloses a sale
By AlphaYouPublished Form 4
Leverone Jason A.
Reporting filer
Leverone Jason A. reported Sale in OnKure Therapeutics, Inc.: 302 units of Class A Common Stock, dated 2026-09-21. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 23, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Leverone Jason A. | 2026-09-21 | S | Sale | 302 | 2.9742 | 18,500 | 2 days | Filed terms
|
Class A Common Stock
- Owner
- Leverone Jason A.
- Date
- 2026-09-21
- Code
- S
- Action
- Sale
- Quantity
- 302
- Price
- 2.9742
- Following holdings
- 18,500
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Class A Common Stock
- transaction Date: 2026-09-21
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 302
- transaction Price Per Share: 2.9742
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 18500
- id: F3
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Leverone Jason A.: Chief Financial Officer.
- F1: These shares were automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"), pursuant to the terms of the Issuer's 2023 RSU Equity Incentive Plan.
- F2: This transaction was executed in multiple trades at prices ranging from $2.95 to $3.06. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- F3: Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
Original sources
Prepared automatically from public filing data. Report a correction.